Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The company says thanks to its proprietary platform, this is a significant advancement for protein production.
February 26, 2026
By: Patrick Lavery
Content Marketing Editor
Validogen (styled VALIDOGEN) is launching its next-generation synthetic methanol-free promoters, which the company says will lead to “substantially increased productivities.”
The launch, according to Validogen, represents a significant advancement for protein production in Pichia pastoris. P. pastoris is a methylotrophic yeast that is one of the main expression systems for production of heterologous proteins.
Also, the launch spotlights Validogen’s proprietary UNLOCK PICHIA platform. Validogen CEO Thomas Purkarthofer said that can offer enhanced productivity, simplified process control, lower oxygen demand, and reduced cooling requirements.
“This new promoter library broadens the range of solutions we can offer our customers,” Purkarthofer said. “In addition, there is no longer a need to identify a manufacturing site equipped to handle methanol at large scale.”
Validogen is a CDMO specializing in recombinant protein expression, strain engineering, and protein production process development. Previously, the company has supported customers by applying both methanol-induced and methanol-free expression systems.
What the new promoters boast is the use of glycerol or glucose as the sole carbon source throughout the process. This avoids the metabolic burden often associated with carbon source switching.
“Controlled, methanol-free expression in Pichia is not new to Validogen,” said company Head of Operations Roland Weis. “What is new is the level of control and productivity that can now be achieved.”
Weis said that the performance observed so far is comparable to—or in some cases, exceeds—methanol-induced systems.
Ultimately, Validogen says, end results may include reduced cost of goods and the facilitation of robust, scalable production processes.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !